Scholarlink

Background <p>Head and Neck Squamous Cell Carcinoma (HNSCC) is one of the most common malignancies worldwide with high morbidity and mortality. Identifying potential biomarkers for prognosis is important to improve clinical outcomes. <i>FRMD5</i>, a gene encoding a 570-amino-acid protein with a <i>FERM</i> domain, plays a role in maintaining cell-cell adhesion at adherens junctions. Its expression is regulated by mutant p53R273H, a variant often found in cancers.</p> Objective <p>This study aimed to assess <i>FRMD5</i> expression in HNSCC and determine its association with patient prognosis.</p> Methods <p><i>FRMD5</i> mRNA expression levels were analyzed using transcriptomic data from The Cancer Genome Atlas (TCGA). The UALCAN platform was used to compare <i>FRMD5</i> levels between tumor and normal tissues, and to observe expression trends across different cancer types. Survival analysis was performed using the Kaplan–Meier plotter, correlating the expression of <i>FRMD5</i> with overall survival (OS) in HNSCC patients. Statistical significance was evaluated to determine the prognostic value of <i>FRMD5</i> expression.</p> Results <p><i>FRMD5</i> was significantly overexpressed in HNSCC tissues compared to normal tissues. Similar overexpression trends were noted in several other tumor types. Survival analysis revealed that patients with high <i>FRMD5</i> expression had notably worse overall survival, suggesting that elevated <i>FRMD5</i> levels are associated with poor clinical outcomes.</p> Conclusion <p><i>FRMD5</i> is markedly upregulated in HNSCC and is associated with decreased survival rates, indicating its potential utility as a prognostic biomarker. Further studies are needed to clarify its role in tumor biology and explore its value as a therapeutic target.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Overexpression of FRMD5 associated with worse prognosis in head and neck squamous cell carcinoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月10日

查看全文
  • Namira K Fateen,
  • Dinesh Yasothkumar,
  • Abilasha Ramasubramanian,
  • Pratibha Ramani

摘要

Background

Head and Neck Squamous Cell Carcinoma (HNSCC) is one of the most common malignancies worldwide with high morbidity and mortality. Identifying potential biomarkers for prognosis is important to improve clinical outcomes. FRMD5, a gene encoding a 570-amino-acid protein with a FERM domain, plays a role in maintaining cell-cell adhesion at adherens junctions. Its expression is regulated by mutant p53R273H, a variant often found in cancers.

Objective

This study aimed to assess FRMD5 expression in HNSCC and determine its association with patient prognosis.

Methods

FRMD5 mRNA expression levels were analyzed using transcriptomic data from The Cancer Genome Atlas (TCGA). The UALCAN platform was used to compare FRMD5 levels between tumor and normal tissues, and to observe expression trends across different cancer types. Survival analysis was performed using the Kaplan–Meier plotter, correlating the expression of FRMD5 with overall survival (OS) in HNSCC patients. Statistical significance was evaluated to determine the prognostic value of FRMD5 expression.

Results

FRMD5 was significantly overexpressed in HNSCC tissues compared to normal tissues. Similar overexpression trends were noted in several other tumor types. Survival analysis revealed that patients with high FRMD5 expression had notably worse overall survival, suggesting that elevated FRMD5 levels are associated with poor clinical outcomes.

Conclusion

FRMD5 is markedly upregulated in HNSCC and is associated with decreased survival rates, indicating its potential utility as a prognostic biomarker. Further studies are needed to clarify its role in tumor biology and explore its value as a therapeutic target.